News FDA Approves First Once-Daily Ophthalmic NSAID for Use in Cataract Surgery by Medscape • 2010/10/25 • 0 Comments The FDA has approved a once-daily formulation of bromfenac 0.09% ophthalmic solution for the treatment of postoperative inflammation and the reduction of ocular pain. Medscape Medical News Full Story →